PROCELLEX

Details for Australian Trade Mark No. 1218711 (hide)

Classes

Class 1 Chemicals used in industry, science, photography, agriculture, horticulture and industry; chemical, biochemical, biological and biotechnological preparations and substances for producing biopharmaceuticals, namely recombinant proteins; chemical, biochemical and biotechnological preparations and substances for industrial, and scientific use, namely, recombinant vectors for cloning and expression of dna; chemical, biochemical, biological and biotechnological preparations and substances for use in the manufacture of recombinant proteins; namely, recombinant vectors for cellular expression of recombinant dna; chemical, biochemical, biological and biotechnological preparations and substances for supporting cellular expression of recombinant proteins, namely, cell growth support structures medium and substrates for use in cell cultures; chemical, biochemical, biological and biotechnological preparations and substances for use in the manufacture of recombinant protein based products, namely, medicines, pharmaceuticals, diagnostics, vaccines, antibodies and biological molecules; chemical, biochemical, biological and biotechnological preparations and substances, namely, recombinant vectors for industrial and scientific use in laboratories, diagnostics and analytics

Class 42 Scientific and technological services and research and design relating thereto; development of a proprietary plant-based production system for the development, expression and manufacture of recombinant proteins; research and development for others in the field of genetically engineered plants and plant cell for producing biopharmaceuticals, namely recombinant proteins; development of new technology for the others in the field of recombinant biotechnology; product research and development; scientific research and industrial research for others, namely, drug discovery, cell discovery, discovery of recombinant proteins, gene research, enzyme research, molecular research, genomics and gene expression research and development; technical consultation in the field of biotechnology and in the field of recombinant production technology

Event Publications

31 January 2008 Application filed

19 February 2009 Application Accepted

11 June 2009 Opposition Filed

NOVARTIS VACCINES AND DIAGNOSTICS, INC has filed an opposition against Protalix Ltd Israel.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.